+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Oxybate Oral Medications Market by Indication, Strength, Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast to 2030- Product Image
Sodium Oxybate Oral Medications Market by Indication, Strength, Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Sodium Oxybate Oral Medications Market by Indication, Strength, Distribution Channel, Dosage Form, End User, Packaging Type, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084840
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Sodium oxybate oral therapies are reshaping the management of sleep disorders, with evolving clinical protocols, policy trends, and rising awareness among both clinicians and patients fueling market momentum. As the competitive environment becomes more dynamic and regulatory landscapes mature, decision-makers require a nuanced view of emerging opportunities and challenges to guide strategic investments in this sophisticated therapeutic sector.

Market Snapshot: Sodium Oxybate Oral Therapies

The sodium oxybate market is experiencing robust growth, driven by increasing recognition of sleep disorders such as idiopathic hypersomnia and narcolepsy, alongside rising demand for effective and well-tolerated oral medications. Industry players are responding with advanced formulations and enhanced delivery systems, while recent changes in tariff policies and a shift towards digital health integration continue to influence cost structures and supply chain strategy. Stakeholders across the value chain are actively optimizing sourcing, pricing, and commercialization approaches to maximize their presence and sustain long-term progress in an intricate regulatory environment.

Scope & Segmentation

This report offers a detailed analysis of the sodium oxybate market, focusing on clinical, commercial, and regional dimensions. The segmentation framework enables a granular assessment of growth drivers and market dynamics across key categories:

  • Indications: Idiopathic hypersomnia, narcolepsy (type one, type two), off-label applications (including Kleine Levin syndrome).
  • Strengths: Four point five gram, six gram, seven point five gram, nine gram dosage forms, addressing diverse patient titration and control needs.
  • Distribution Channels: Hospital, specialty, retail, and online pharmacies serving both acute and home-based care models.
  • Dosage Forms: Liquid for precise dosing requirements, powder sachets optimized for portability and shelf life stability.
  • End Users: Home care settings, inpatient hospitals, and specialty clinics facilitating both initiation and maintenance therapy.
  • Packaging Types: Multi-dose and single-dose solutions to accommodate adherence and convenience considerations.
  • Patient Age Groups: Adults and pediatric patients with variable safety and monitoring protocols.
  • Regions: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Companies: Market analysis covers Jazz Pharmaceuticals plc, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Inc, Breckenridge Pharmaceutical, Inc, Alvogen Pharma GmbH, Apotex Inc, Par Pharmaceutical Companies, Inc, Lupin Limited, and Sun Pharmaceutical Industries Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • Sodium oxybate’s dual-action mechanism offers restorative sleep benefits and cataplexy mitigation, prompting tailored dosing and broadening clinical adoption.
  • Patent expirations are catalyzing innovation among originators and generics, resulting in diversified strengths and delivery formats that better match specific patient needs.
  • Digital health integration, including real-time sleep pattern monitoring and remote adherence support, is improving therapy outcomes and driving operational efficiencies.
  • Distribution strategies are evolving, with specialty pharmacies and online platforms increasingly pivotal for enhancing both access and patient experience.
  • Segmentation by indication, age, and region allows companies to customize their commercial approaches and patient support services more effectively.
  • Robust evidence generation, particularly around outcomes and cost-efficiency, is strengthening the value proposition for payers and supporting wider reimbursement.

2025 US Tariff Impact on Supply Chains

Recent US tariff revisions have imposed higher duties on critical sodium oxybate raw materials, prompting manufacturers to recalibrate procurement strategies and diversify suppliers. While short-term inflation in input costs has necessitated selective price adjustments, these measures have driven a shift toward optimized production and localized manufacturing, building greater resilience into the supply chain. Stakeholders responding proactively to these changes are better poised to secure market share and maintain competitive pricing amidst ongoing trade uncertainty.

Methodology & Data Sources

This analysis leverages a comprehensive multi-method approach, combining in-depth interviews with clinicians, industry leaders, and advocacy representatives with secondary research from regulatory filings, peer-reviewed publications, company disclosures, and specialty pharmacy distribution data. Rigorous triangulation ensures all findings are empirically validated and actionable.

Sodium Oxybate Oral Therapies: Why This Report Matters

  • Provides a strategic foundation for investment, portfolio optimization, and market entry in the evolving sodium oxybate segment.
  • Equips executive leadership with granular segmentation and regional adoption insights essential for successful operational and commercialization planning.
  • Enables informed adaptation to policy changes, technological advances, and competitive shifts, supporting sustainable business performance.

Conclusion

The sodium oxybate oral medications market is advancing as clinical innovation, targeted segmentation, and policy adaptation reshape its landscape. Stakeholders applying these insights can navigate complexity, unlock new growth avenues, and deliver impactful patient outcomes.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sodium Oxybate Oral Medications Market, by Indication
8.1. Introduction
8.2. Idiopathic Hypersomnia
8.3. Narcolepsy
8.3.1. Type One Narcolepsy
8.3.2. Type Two Narcolepsy
8.4. Off-Label Use
8.4.1. Kleine Levin Syndrome
9. Sodium Oxybate Oral Medications Market, by Strength
9.1. Introduction
9.2. Four Point Five Gram
9.3. Nine Gram
9.4. Seven Point Five Gram
9.5. Six Gram
10. Sodium Oxybate Oral Medications Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.5. Specialty Pharmacies
11. Sodium Oxybate Oral Medications Market, by Dosage Form
11.1. Introduction
11.2. Liquid
11.3. Powder
12. Sodium Oxybate Oral Medications Market, by End User
12.1. Introduction
12.2. Home Care
12.3. Hospitals
12.4. Specialty Clinics
13. Sodium Oxybate Oral Medications Market, by Packaging Type
13.1. Introduction
13.2. Multi Dose
13.3. Single Dose
14. Sodium Oxybate Oral Medications Market, by Patient Age Group
14.1. Introduction
14.2. Adults
14.3. Pediatrics
15. Americas Sodium Oxybate Oral Medications Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Sodium Oxybate Oral Medications Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Sodium Oxybate Oral Medications Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Jazz Pharmaceuticals plc
18.3.2. Hikma Pharmaceuticals PLC
18.3.3. Teva Pharmaceutical Industries Ltd
18.3.4. Amneal Pharmaceuticals Inc
18.3.5. Breckenridge Pharmaceutical, Inc
18.3.6. Alvogen Pharma GmbH
18.3.7. Apotex Inc
18.3.8. Par Pharmaceutical Companies, Inc
18.3.9. Lupin Limited
18.3.10. Sun Pharmaceutical Industries Ltd
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET MULTI-CURRENCY
FIGURE 2. SODIUM OXYBATE ORAL MEDICATIONS MARKET MULTI-LANGUAGE
FIGURE 3. SODIUM OXYBATE ORAL MEDICATIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SODIUM OXYBATE ORAL MEDICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SODIUM OXYBATE ORAL MEDICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SODIUM OXYBATE ORAL MEDICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 60. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 61. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 62. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 64. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 115. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 117. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 119. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 124. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 126. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 142. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 143. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 144. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 146. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 148. ITALY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 150. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 151. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 152. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 153. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 155. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 185. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 187. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 188. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 189. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 205. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 206. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 207. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 209. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 211. QATAR SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 214. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 215. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 216. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 218. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 241. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 243. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 245. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 250. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 251. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 252. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 254. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 268. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 269. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 270. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 272. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 277. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 278. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 279. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 281. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 303. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 304. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2030 (USD MILLION)
TABLE 305. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2030 (USD MILLION)
TABLE 306. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2030 (USD MILLION)
TABLE 30

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sodium Oxybate Oral Medications market report include:
  • Jazz Pharmaceuticals plc
  • Hikma Pharmaceuticals PLC
  • Teva Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals Inc
  • Breckenridge Pharmaceutical, Inc
  • Alvogen Pharma GmbH
  • Apotex Inc
  • Par Pharmaceutical Companies, Inc
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd

Related Topics

Related Reports

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Market Report 2025 - Product Image

Narcolepsy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Narcolepsy Drugs Market Report 2025 - Product Image

Narcolepsy Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.